Valkyrie Pharma’s Primobolan product received high marks for the second time from AnabolicLab.
Valkyrie Pharma products have been subjected to laboratory testing on multiple occasions since the launch of AnabolicLab. AnabolicLab has now tested Valkyrie Pharma’s Primobolan 100 for the second time. And the results are even better than before.
SIMEC performed its latest analysis of Primobolan 100 in February 2018. The label tells us that there should be 100 milligrams of methenolone enanthate per milliliter of injectable solution. And the lab test results tell us there is actually 100.6 mg/ml. That is 0.6% outside of the label claim.
New lab report: Valkyrie Pharmaceutical Primobolan 100 Lab Test Results https://t.co/1sv9MSyQ4M #harmreduction #steroids
— Anabolic Lab (@AnabolicLab) March 22, 2018
The 2018 version of Valkyrie’s Primobolan 100 is better than the 2016 version.
It is always good when a product passes the AnabolicLab analysis. But just because one batch of product passes, it does not mean that all batch are of similar quality.
However, consumer confidence increases exponentially when multiple batches pass the rigorous laboratory analysis.
Valkyrie Pharma Primobolan 100 batch number “XFR3666” was tested in August 2016. It contained 106.2 mg/ml methenolone enanthate. It is a little more than 6% over label claim.
This was already an excellent result.
Nonetheless, Valkyrie Pharma improved upon it with batch number “HGM5685” in February 2018. A product that is 0.6% over label claim is better than 6% over label claim.
Bodybuilding consumers can take comfort in the fact that Valkyrie’s Primobolan product has passed AnabolicLab testing twice.
“The 2018 version of Valkyrie’s Primobolan 100 is better than the 2016 version.”